Plain-English translation of NCT07204977 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
United States
Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Enrollment target
~30 participants
Started
February 2026
Primary completion
September 2027
Age range
18 Years – 99 Years
Last updated on clinicaltrials.gov in May 2026.